This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arima, H. Articles by Aguilera, G. Search for Related Content PubMed PubMed Citation Articles by Arima, H. Articles by Aguilera, G.

Neuronal Activity Is Required for the Circadian Rhythm of Vasopressin Gene Transcription in the Suprachiasmatic Nucleus in Vitro

Section on Endocrine Physiology (H.A., G.A.), Developmental Endocrinology Brach, National Institute of Child Health and Human Development, and Laboratory of Neurochemistry (H.G.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Hiroshi Arima, First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Syowa-ko, Nagoya 466-8550, Japan. E-mail: arima105{at}med.nagoya-u.ac.jp

Arginine vasopressin (AVP) is synthesized in and secreted by the suprachiasmatic nucleus (SCN) in a circadian pattern. Transcription of the AVP gene in organotypic cultures of rat SCN was studied by using an intronic in situ hybridization. AVP gene transcription in the cultured SCN maintained a daily rhythm with a peak in the daytime. Inhibition of spontaneous activity by the sodium channel blocker, tetrodotoxin (TTX), dramatically decreased AVP heteronuclear RNA levels and suppressed rhythmicity, indicating that ongoing neural activity was required for the AVP gene transcription. In the presence of TTX, the adenylate cyclase stimulator, forskolin, increased AVP transcription in the SCN. In contrast, the protein kinase C activator, phorbol 12-myristate 13-acetate, greatly increased AVP transcription in the absence of TTX, but this effect was blocked by TTX, indicating that the phorbol 12-myristate 13-acetate acted indirectly via synaptic input. Neither protein kinase A nor protein kinase C pathways appear to be involved in the rhythmicity of AVP transcription in the SCN because selective inhibitors of these protein kinases were without effect. In contrast, the MAPK pathway inhibitor, PD98059, profoundly decreased AVP transcription and abolished its daily rhythm. Hence, a functional MAPK signaling pathway appears to be critical for AVP gene expression in the SCN.

This article has been cited by other articles:

				H. Shimizu, H. Arima, M. Watanabe, M. Goto, R. Banno, I. Sato, N. Ozaki, H. Nagasaki, and Y. Oiso Glucocorticoids Increase Neuropeptide Y and Agouti-Related Peptide Gene Expression via Adenosine Monophosphate-Activated Protein Kinase Signaling in the Arcuate Nucleus of Rats Endocrinology, September 1, 2008; 149(9): 4544 - 4553. [Abstract] [Full Text] [PDF]

				M. Akashi, N. Hayasaka, S. Yamazaki, and K. Node Mitogen-Activated Protein Kinase Is a Functional Component of the Autonomous Circadian System in the Suprachiasmatic Nucleus J. Neurosci., April 30, 2008; 28(18): 4619 - 4623. [Abstract] [Full Text] [PDF]

				Y. Kwak, G. B. Lundkvist, J. Brask, A. Davidson, M. Menaker, K. Kristensson, and G. D. Block Interferon-{gamma} Alters Electrical Activity and Clock Gene Expression in Suprachiasmatic Nucleus Neurons J Biol Rhythms, April 1, 2008; 23(2): 150 - 159. [Abstract] [PDF]

				E. S. Maywood, J. S. O'Neill, J. E. Chesham, and M. H. Hastings Minireview: The Circadian Clockwork of the Suprachiasmatic Nuclei Analysis of a Cellular Oscillator that Drives Endocrine Rhythms Endocrinology, December 1, 2007; 148(12): 5624 - 5634. [Abstract] [Full Text] [PDF]

				M. Rusnak, Z. E. Toth, S. B. House, and H. Gainer Depolarization and Neurotransmitter Regulation of Vasopressin Gene Expression in the Rat Suprachiasmatic Nucleus In Vitro J. Neurosci., January 3, 2007; 27(1): 141 - 151. [Abstract] [Full Text] [PDF]

				M. Goto, H. Arima, M. Watanabe, M. Hayashi, R. Banno, I. Sato, H. Nagasaki, and Y. Oiso Ghrelin Increases Neuropeptide Y and Agouti-Related Peptide Gene Expression in the Arcuate Nucleus in Rat Hypothalamic Organotypic Cultures Endocrinology, November 1, 2006; 147(11): 5102 - 5109. [Abstract] [Full Text] [PDF]

				C. Yue, N. Mutsuga, E. M. Scordalakes, and H. Gainer Studies of oxytocin and vasopressin gene expression in the rat hypothalamus using exon- and intron-specific probes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1233 - R1241. [Abstract] [Full Text] [PDF]

				I. Sato, H. Arima, N. Ozaki, M. Watanabe, M. Goto, M. Hayashi, R. Banno, H. Nagasaki, and Y. Oiso Insulin Inhibits Neuropeptide Y Gene Expression in the Arcuate Nucleus through GABAergic Systems J. Neurosci., September 21, 2005; 25(38): 8657 - 8664. [Abstract] [Full Text] [PDF]

				M. H. Hastings and E. D. Herzog Clock Genes, Oscillators, and Cellular Networks in the Suprachiasmatic Nuclei J Biol Rhythms, October 1, 2004; 19(5): 400 - 413. [Abstract] [PDF]

				A. T. Hughes, B. Fahey, D. J. Cutler, A. N. Coogan, and H. D. Piggins Aberrant Gating of Photic Input to the Suprachiasmatic Circadian Pacemaker of Mice Lacking the VPAC2 Receptor J. Neurosci., April 7, 2004; 24(14): 3522 - 3526. [Abstract] [Full Text] [PDF]

				S. Kuwahara, H. Arima, R. Banno, I. Sato, N. Kondo, and Y. Oiso Regulation of Vasopressin Gene Expression by cAMP and Glucocorticoids in Parvocellular Neurons of the Paraventricular Nucleus in Rat Hypothalamic Organotypic Cultures J. Neurosci., November 12, 2003; 23(32): 10231 - 10237. [Abstract] [Full Text] [PDF]

				A. N. Coogan and H. D. Piggins Circadian and Photic Regulation of Phosphorylation of ERK1/2 and Elk-1 in the Suprachiasmatic Nuclei of the Syrian Hamster J. Neurosci., April 1, 2003; 23(7): 3085 - 3093. [Abstract] [Full Text] [PDF]